Report error Found 26 Enz. Inhib. hit(s) with all data for entry = 50012432
Affinity DataEC50: 48nMAssay Description:Orthosteric agonist activity at recombinant human N-terminal His6-tagged RORgammat ligand binding domain (265 to 518 residues) expressed in Escherich...More data for this Ligand-Target Pair
Affinity DataEC50: 27nMAssay Description:Orthosteric agonist activity at recombinant human N-terminal His6-tagged RORgammat ligand binding domain (265 to 518 residues) expressed in Escherich...More data for this Ligand-Target Pair
Affinity DataEC50: 418nMAssay Description:Orthosteric agonist activity at recombinant human N-terminal His6-tagged RORgammat ligand binding domain (265 to 518 residues) expressed in Escherich...More data for this Ligand-Target Pair
Affinity DataIC50: 1.30nMAssay Description:Allosteric inverse agonist activity at 2-chloro-5-nitro-N-(2-(trifluoromethyl)phenyl)benzamide-ligated recombinant human N-terminal His6-tagged RORga...More data for this Ligand-Target Pair
Affinity DataIC50: 5.5nMAssay Description:Allosteric inverse agonist activity at 2-chloro-N-(2,6-dimethylphenyl)-5-nitrobenzamide-ligated recombinant human N-terminal His6-tagged RORgammat li...More data for this Ligand-Target Pair
Affinity DataIC50: 5.5nMAssay Description:Allosteric inverse agonist activity at 2-chloro-5-nitro-N-o-tolylbenzamide-ligated recombinant human N-terminal His6-tagged RORgammat ligand binding ...More data for this Ligand-Target Pair
Affinity DataIC50: 17nMAssay Description:Allosteric inverse agonist activity at recombinant human N-terminal His6-tagged RORgammat ligand binding domain (265 to 518 residues) expressed in Es...More data for this Ligand-Target Pair
Affinity DataIC50: 40nMAssay Description:Allosteric inverse agonist activity at 2-chloro-N-(2,6-dimethylphenyl)-5-nitrobenzamide-ligated recombinant human N-terminal His6-tagged RORgammat li...More data for this Ligand-Target Pair
Affinity DataIC50: 67nMAssay Description:Orthosteric inverse agonist activity at recombinant human N-terminal His6-tagged RORgammat ligand binding domain (265 to 518 residues) expressed in E...More data for this Ligand-Target Pair
Affinity DataIC50: 68nMAssay Description:Allosteric inverse agonist activity at 2-chloro-5-nitro-N-(2-(trifluoromethyl)phenyl)benzamide-ligated recombinant human N-terminal His6-tagged RORga...More data for this Ligand-Target Pair
Affinity DataIC50: 77nMAssay Description:Orthosteric inverse agonist activity at recombinant human N-terminal His6-tagged RORgammat ligand binding domain (265 to 518 residues) expressed in E...More data for this Ligand-Target Pair
Affinity DataIC50: 80nMAssay Description:Allosteric inverse agonist activity at 2-chloro-5-nitro-N-o-tolylbenzamide-ligated recombinant human N-terminal His6-tagged RORgammat ligand binding ...More data for this Ligand-Target Pair
Affinity DataIC50: 81nMAssay Description:Orthosteric inverse agonist activity at recombinant human N-terminal His6-tagged RORgammat ligand binding domain (265 to 518 residues) expressed in E...More data for this Ligand-Target Pair
Affinity DataIC50: 86nMAssay Description:Orthosteric inverse agonist activity at recombinant human N-terminal His6-tagged RORgammat ligand binding domain (265 to 518 residues) expressed in E...More data for this Ligand-Target Pair
Affinity DataIC50: 89nMAssay Description:Orthosteric inverse agonist activity at recombinant human N-terminal His6-tagged RORgammat ligand binding domain (265 to 518 residues) expressed in E...More data for this Ligand-Target Pair
Affinity DataIC50: 94nMAssay Description:Orthosteric inverse agonist activity at recombinant human N-terminal His6-tagged RORgammat ligand binding domain (265 to 518 residues) expressed in E...More data for this Ligand-Target Pair
Affinity DataIC50: 108nMAssay Description:Orthosteric inverse agonist activity at recombinant human N-terminal His6-tagged RORgammat ligand binding domain (265 to 518 residues) expressed in E...More data for this Ligand-Target Pair
Affinity DataIC50: 122nMAssay Description:Orthosteric inverse agonist activity at recombinant human N-terminal His6-tagged RORgammat ligand binding domain (265 to 518 residues) expressed in E...More data for this Ligand-Target Pair
Affinity DataIC50: 131nMAssay Description:Orthosteric inverse agonist activity at recombinant human N-terminal His6-tagged RORgammat ligand binding domain (265 to 518 residues) expressed in E...More data for this Ligand-Target Pair
Affinity DataIC50: 404nMAssay Description:Orthosteric inverse agonist activity at recombinant human N-terminal His6-tagged RORgammat ligand binding domain (265 to 518 residues) expressed in E...More data for this Ligand-Target Pair
Affinity DataIC50: 428nMAssay Description:Allosteric inverse agonist activity at recombinant human N-terminal His6-tagged RORgammat ligand binding domain (265 to 518 residues) expressed in Es...More data for this Ligand-Target Pair
Affinity DataIC50: 1.08E+3nMAssay Description:Orthosteric inverse agonist activity at recombinant human N-terminal His6-tagged RORgammat ligand binding domain (265 to 518 residues) expressed in E...More data for this Ligand-Target Pair
Affinity DataIC50: 2.31E+3nMAssay Description:Orthosteric inverse agonist activity at recombinant human N-terminal His6-tagged RORgammat ligand binding domain (265 to 518 residues) expressed in E...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+4nMAssay Description:Orthosteric inverse agonist activity at 2-chloro-5-nitro-N-o-tolylbenzamide-ligated recombinant human N-terminal His6-tagged RORgammat ligand binding...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+4nMAssay Description:Orthosteric inverse agonist activity at 2-chloro-N-(2,6-dimethylphenyl)-5-nitrobenzamide-ligated recombinant human N-terminal His6-tagged RORgammat l...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+4nMAssay Description:Orthosteric inverse agonist activity at 2-chloro-5-nitro-N-(2-(trifluoromethyl)phenyl)benzamide-ligated recombinant human N-terminal His6-tagged RORg...More data for this Ligand-Target Pair


3D Structure (crystal)













